Rankings
▼
Calendar
AXGN FY 2021 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena
AXGN
AxoGen, Inc.
$2B
FY 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$127M
+13.4% YoY
Gross Profit
$104M
82.0% margin
Operating Income
-$25M
-20.0% margin
Net Income
-$27M
-21.2% margin
EPS (Diluted)
$-0.65
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$42M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$208M
Total Liabilities
$95M
Stockholders' Equity
$113M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$127M
$112M
+13.4%
Gross Profit
$104M
$91M
+15.1%
Operating Income
-$25M
-$23M
-9.6%
Net Income
-$27M
-$24M
-13.4%
← Q4 2020
All Quarters
Q1 2021 →